Supramolecular assembly of rifampicin and PEGylated PAMAM dendrimer as a novel conjugate for tuberculosis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Supramolecular assembly of rifampicin and PEGylated PAMAM dendrimer as a novel conjugate for tuberculosis
Authors
Keywords
PAMAM dendrimer, PEGylated dendrimer, Tuberculosis, Rifampicin, In vitro, drug release, Nanoparticle
Journal
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
Volume 66, Issue -, Pages 102773
Publisher
Elsevier BV
Online
2021-08-21
DOI
10.1016/j.jddst.2021.102773
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PEGylated poly(amidoamine) dendrimers-based drug loading vehicles for delivering carboplatin in treatment of various cancerous cells
- (2019) Minh Nhat Ho et al. JOURNAL OF NANOPARTICLE RESEARCH
- Polyamidoamine (PAMAM) dendrimers as potential release modulators and oral bioavailability enhancers of vardenafil hydrochloride
- (2018) Mai Ahmed Tawfik et al. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
- Antimycobacterial susceptibility evaluation of rifampicin and isoniazid benz-hydrazone in biodegradable polymeric nanoparticles against Mycobacterium tuberculosis H37Rv strain
- (2018) Sushruta Hakkimane et al. International Journal of Nanomedicine
- Partially PEGylated PAMAM dendrimers as solubility enhancers of Silybin
- (2017) Carola Diaz et al. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
- A poly(amidoamine) dendrimer-based drug carrier for delivering DOX to gliomas cells
- (2017) Yan Li et al. RSC Advances
- PEGylated PAMAM dendrimers: Enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery
- (2016) Duy Luong et al. Acta Biomaterialia
- DLS and zeta potential – What they are and what they are not?
- (2016) Sourav Bhattacharjee JOURNAL OF CONTROLLED RELEASE
- Association of the anti-tuberculosis drug rifampicin with a PAMAM dendrimer
- (2015) Reinaldo G. Bellini et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Impact of pegylation on biopharmaceutical properties of dendrimers
- (2015) Shrikant Thakur et al. POLYMER
- Development and Characterization of Liposomal Doxorubicin Hydrochloride with Palm Oil
- (2014) Bahareh Sabeti et al. Biomed Research International
- Phase I, Single-Dose, Dose-Escalating Study of Inhaled Dry Powder Capreomycin: a New Approach to Therapy of Drug-Resistant Tuberculosis
- (2013) Ashwin S. Dharmadhikari et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pegylated Dendrimer and Its Effect in Fluorouracil Loading and Release for Enhancing Antitumor Activity
- (2013) Tu Uyen Ly et al. Journal of Biomedical Nanotechnology
- Chitosan Nanoparticles Attenuate Hydrogen Peroxide-Induced Stress Injury in Mouse Macrophage RAW264.7 Cells
- (2013) Zheng-Shun Wen et al. Marine Drugs
- A new respirable form of rifampicin
- (2011) Yoen-Ju Son et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Effects of PEGylation on the Size and Internal Structure of Dendrimers: Self-Penetration of Long PEG Chains into the Dendrimer Core
- (2011) Hwankyu Lee et al. MACROMOLECULES
- The near future: Improving the activity of rifamycins and pyrazinamide
- (2010) D.A. Mitchison et al. TUBERCULOSIS
- Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: The effects of PEGylation degree and drug conjugation style
- (2009) Saijie Zhu et al. BIOMATERIALS
- Surface-Engineered Dendrimers: a Solution for Toxicity Issues
- (2009) Vijay Mishra et al. JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
- PEGylated PAMAM Dendrimer-Doxorubicin Conjugates: In Vitro Evaluation and In Vivo Tumor Accumulation
- (2009) Saijie Zhu et al. PHARMACEUTICAL RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started